相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
The Prognostic Role of mTOR and P-mTOR for Survival in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Lei Li et al.
PLOS ONE (2015)
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
Christian Rolfo et al.
CANCER TREATMENT REVIEWS (2014)
p-mTOR expression is associated with better prognosis in luminal breast carcinoma
Francisco Beca et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Fabrice Andre et al.
LANCET ONCOLOGY (2014)
Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer
Georgios Lazaridis et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
Elisavet Paplomata et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Karin Beelen et al.
BREAST CANCER RESEARCH (2014)
Immunohistochemical Expression of Phospho-mTOR Is Associated With Poor Prognosis in Patients With Gallbladder Adenocarcinoma
Pamela Leal et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison
Glaucia F. Cota et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas
Panagiotis Bakarakos et al.
HISTOPATHOLOGY (2010)
Phosphorylated Akt and Phosphorylated mTOR Expression in Breast Invasive Carcinomas: Analysis of 530 Cases
Jungsuk An et al.
JOURNAL OF BREAST CANCER (2010)
High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma
Valsamo K. Anagnostou et al.
CLINICAL CANCER RESEARCH (2009)
Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer
Guanzhen Yu et al.
CLINICAL CANCER RESEARCH (2009)
Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer
Henna Heinonen et al.
BMC GENOMICS (2008)
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
R. L. Dillon et al.
ONCOGENE (2007)
MTOR, translation initiation and cancer
Y. Mamane et al.
ONCOGENE (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
The Akt pathway in human breast cancer: a tissue-array-based analysis
S Bose et al.
MODERN PATHOLOGY (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
mTOR: a protein kinase switching between life and death
L Asnaghi et al.
PHARMACOLOGICAL RESEARCH (2004)
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
XY Zhou et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
